Apyx Medical Corp Accrued Sales Commission, Current
Apyx Medical Corp (APYX) had Accrued Sales Commission, Current of $961.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedSalesCommissionCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Sales Commission, Current $961.00K.
- 2026-03-31: Accrued Sales Commission, Current $607.00K.
- 2025-12-31: Accrued Sales Commission, Current $958.00K.
- 2025-09-30: Accrued Sales Commission, Current $787.00K.
| Period end | Accrued Sales Commission, Current |
|---|---|
| 2026-06-30 | $961.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $607.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $958.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $787.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $589.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $526.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $981.00K 10-K · filed 2026-03-10 |
| 2024-09-30 | $641.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $625.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $576.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.49M 10-K · filed 2025-03-13 |
| 2023-09-30 | $1.18M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.23M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $790.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $847.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | $877.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.07M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $954.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.66M 10-K · filed 2023-03-16 |
| 2021-09-30 | $897.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $730.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $748.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.00M 10-K · filed 2022-03-17 |
| 2020-09-30 | $620.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $531.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $375.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $877.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $784.00K 10-Q · filed 2019-11-15 |
| 2018-12-31 | $379.00K 10-K · filed 2020-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |